Fredrickson JU

No ORCID on file · 1 paper in corpus
observational 2024
Gynecologic Oncology ·doi:10.1016/j.ygyno.2024.07.690

BACKGROUND: Individuals with germline BRCA1 and BRCA2 pathogenic variants (BRCA carriers) are at high risk of developing high grade serous ovarian carcinoma (HGSC). HGSC is predominantly driven by TP53 mutations, but mutations in this gene …